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Outbreak of ST395 KPC-Producing Klebsiella
pneumoniae in a Neonatal Intensive Care Unit
in Palermo, Italy
To the Editor—The spread of carbapenem-resistant Klebsiella
pneumoniae (CR-Kp) is an emerging concern worldwide. Italy
is a country endemic for Klebsiella pneumoniae carbapene-
mases (KPCs).1,2 KPC spread in neonatal intensive care units
(NICUs) may represent a major safety issue for critical infants
and a challenge in managing new admissions.3 In February
2014, we started an active surveillance program for coloniza-
tion by multidrug-resistant organisms in 5 NICUs in Palermo,
Italy. Inclusion criteria for patients were hospitalization for at
least 48 hours and collection of at least 1 rectal swab. Samples
were collected monthly in each NICU and cultured on
selective media. A gram-negative bacterium resistant to at
least 3 different groups of antimicrobial agents (eg, penicillins,
cephalosporins, aminoglycosides, and/or carbapenems) was
deﬁned as a multidrug-resistant gram-negative (MDRGN).
Colonization was deﬁned as the isolation of an MDRGN
without evidence of infection.
Swabs were inoculated onto MacConkey agar plates with
4 antibiotic disks containing gentamicin, amoxicillin-
clavulanic acid, meropenem, and ceftazidime and were then
incubated. Colonies growing into each antibiotic inhibition
halo were subcultured, and biochemical identiﬁcation of
isolated strains was performed using the API 20E system
(BioMerieux, Marcy-l’Etoile, France). Antibiotic susceptibility
testing was performed using a disk diffusion (DD) method on
Mueller-Hinton agar plates with a panel of antimicrobials
(ie, netilmicin, amoxicillin-clavulanic acid, cefotaxime, cefta-
zidime, ceftriaxone, cefepime, imipenem, aztreonam, and
gentamicin) according to the Clinical and Laboratory
Standards Institute guidelines.4 Colonies growing within
meropenem and imipenem inhibition zones were subjected to
E-test strips (BioMerieux, Marcy-l’Etoile, France) for
minimum inhibitory concentration (MIC) determination.
Antibiotic susceptibility testing and extended spectrum
β-lactamase (ESBL) detection were performed using DD and a
double-disk synergy test.
In December 2016, rectal swabs from 6 patients in 1 NICU
identiﬁed these patients as colonized by CR-Kp, and 8 isolates
were collected. Klebsiella pneumoniae strains showing an
extended drug-resistant phenotype were screened by
polymerase chain reaction (PCR) for the following
plasmid-mediated quinolone and β-lactamase genes: qnrB,
aac(6’)-Ib-cr, blaKPC, and blaCTX-M.
2 Positive amplicons were
sequenced to identify the resistance gene variants. Isolates were
initially screened using PCR for the pilv-1 allele as a marker
tracing the sequence type 258 (ST258).5 Complete multilocus
sequence typing (MLST) was then performed on all CR-Kp
strains, and STs were assigned at the K. pneumoniae MLST
website (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html).
The ﬁrst 5 cases of colonization by CR-Kp were identiﬁed on
December 12, 2016. Thereafter, additional collection of rectal
swabs was performed weekly until the end of the spread of the
colonization cluster was proven on January 9, 2017. Coloni-
zation cluster and reported colonization cases are shown in
Figure 1. All 8 CR-Kp isolates were resistant to amoxicillin-
clavulanic acid, cefotaxime, ceftazidime, ceftriaxone, cefepime,
imipenem, aztreonam, and gentamicin and showed an
intermediate susceptibility to netilmicin. The MIC values for
imipenem and meropenem were ≥16 μg/mL. The PCR
results for all 8 CR-Kp isolates were positive for the blaKPC-3,
blaCTX-M-15, and aac(6’)-Ib-cr genes and negative for pilv-1.
Only 1 isolate (from patient 11) tested positive for qnrB.
According to MLST, 7 of 8 isolates were identiﬁed as ST395,
whereas the qnrB-positive isolate from patient 11 was identi-
ﬁed as ST307. All infants included in our previous monthly
surveillance activity on November 21 tested negative. All
CR-Kp–colonized infants, with the exception of patient 12
(who was admitted on December 3, 2016, from another
hospital outside Palermo for feeding difﬁculties) and
patient 17, were inborn. In addition to the active surveillance
program, patients 1, 12, and 17 were tested at admission with a
rectal swab that showed a negative result. No microbiological
data were available before December 12, 2016, to clearly
identify the index patient. The simultaneous isolation of
5 CR-Kp strains was rapidly communicated to healthcare
workers on the ward to control the spread to other patients.
No cases of infection were reported in the colonized patients or
in other infants admitted in the same weeks. The strict colla-
boration between laboratory staff and clinicians allowed a
careful management of patients with adequate cohorting of
colonized patients to avoid any restriction of new admissions
to the NICU. Moreover, the molecular typing of the 8 isolates
identiﬁed 1 different from the cluster, but no data were avail-
able from which to hypothesize a different source. We also
performed whole-genome sequencing with a standard
2 × 100 PE protocol on a HiSeq 2500 instrument (Illumina,
San Diego, CA)6 and compared the genetic structures of all the
isolated KPC-3-Kp ST395. For these isolates, cluster analysis
based on MLST genes indicated a unique sublineage (or clonal
group) of K. pneumoniae. This is not the ﬁrst report of an
outbreak of colonization by KPC-producing K. pneumoniae
(KPC-Kp) in a NICU in Palermo; the pandemic ST258 clone
has already been reported in another NICU here.3 Further-
more, in our area, the monoclonal spread of the successful
pandemic ST258 clone is apparently being replaced by a
simultaneous dissemination of multiple clones of KPC-Kp.7
In other recent surveillance studies from Italy,2,8,9 multifocal
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dissemination of KPC-3–producing K. pneumoniae (KPC-3-Kp)
clones have been observed, showing the rapid emergence of the
KPC-3-Kp ST307 clone, also coproducing the CTX-M-15
ESBL.10 Our observation of ST395 and ST307 clones
(both coproducing KPC-3 and CTX-M-15 ESBL) suggests the
changing epidemiology of KPC-Kp even in speciﬁc settings such
as NICUs. In conclusion, we emphasize the need for active
surveillance programs focused on CR-Kp in high-risk patients
and wards, such as critical infants in NICUs. Surveillance data
from colonization cases could be crucial to revealing the circu-
lation of CR-Kp in the wards, to evaluating local epidemiology,
and to improving control and prevention measures.
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